New insights into factors affecting clot stability: A role for thrombin activatable fibrinolysis inhibitor (TAFI; Plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R)

被引:30
作者
Bouma, BN
Meijers, JCM
机构
[1] Scripps Res Inst, Dept Mol & Expt Med MEM180, La Jolla, CA 92037 USA
[2] Univ Med Ctr, Dept Hematol, Thrombosis & Hemostasis Lab, Utrecht, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1053/j.seminhematol.2003.11.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:13 / 19
页数:7
相关论文
共 66 条
[61]  
WAGENAAR GTM, 2001, THROMB HAEMOST ABS S
[62]  
Walker J. B., 1998, Fibrinolysis and Proteolysis, V12, P11
[63]   A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor [J].
Wang, W ;
Boffa, PB ;
Bajzar, L ;
Walker, JB ;
Nesheim, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (42) :27176-27181
[64]  
WANG W, 1994, J BIOL CHEM, V269, P15937
[65]   Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk [J].
Wolberg, AS ;
Monroe, DM ;
Roberts, HR ;
Hoffman, M .
BLOOD, 2003, 101 (08) :3008-3013
[66]  
Zhao L, 1998, THROMB HAEMOSTASIS, V80, P949